Picture of Lavipharm SA logo

LAVI Lavipharm SA News Story

0.000.00%
gr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million

April 9 (Reuters) - Lavipharm SA LPHr.AT:

TO ACQUIRE DUROGESIC PAIN PATCH RIGHTS IN 24 COUNTRIES FROM JANSSEN

UPFRONT PAYMENT FOR DUROGESIC ACQUISITION $12.0 MILLION

TRANSACTION EXPECTED TO BOOST ANNUAL SALES BY MORE THAN 60%

EXPORT ACTIVITY EXPECTED TO GROW BY MORE THAN 150%

Further company coverage: [LPHr.AT]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))

Recent news on Lavipharm SA

See all news